SCHEMBL7679593

SCHEMBL7679593

CCc1cccc2c1CN(C(CCC(=O)O)C(=O)O)C2=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
MAPK1 P28482 2/20 0.51
HSD17B10 Q99714 2/20 0.51
TP53 P04637 1/20 0.51
GLA P06280 1/20 0.51
POLB P06746 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX12 P18054 1/20 0.51
NFKB1 P19838 1/20 0.51
APEX1 P27695 1/20 0.51
ALOX15 P16050 3/20 0.48
MAPT P10636 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TYMS P04818 2/20 0.42
DHFR P00374 4/20 0.41
STAT3 P40763 1/20 0.39
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7680060 0.92 KDM4E (0.48) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7677476 0.91 KDM4E (0.43) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7675322 0.91 ALOX15 (0.46) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7676549 0.90 KDM4E (0.46) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7680451 0.88 ALOX15 (0.45) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7849722 0.86 KDM4E (0.52) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7673082 0.86 KDM4E (0.52) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL7677784 0.84 KDM4E (0.50) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL14506392 0.84 KDM4E (0.52) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL2169035 0.84 KDM4E (0.52) KDM4EALDH1A1HPGDMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
CN-1342146-A Substituted 1-oxo-and 1, 3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels CELGENE CORP (US) 2002-03-27 CN disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed